Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells

Related articles

1. MHC-II antigen presentation on cancer cells improves CD4+ T cell immunity and vaccine efficacy

   This article has 18 authors:

   1. Tyler Jacks
   2. Sean-Luc Shanahan
   3. Laura Maiorino
   4. Jia-Yun Chen
   5. Nischal Bhandari
   6. Jia-Ren Lin
   7. B.J. Kim
   8. Jonathan Dye
   9. Francis Kassama
   10. Nicolas Mathey-Andrews
   11. Leena Hamad
   12. Emma Dawson
   13. Christina Cabana
   14. Linette Rodriguez
   15. Alex Jaeger
   16. Peter Westcott
   17. Sandro Santagata
   18. Darrell Irvine

2. Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy Response

   This article has 20 authors:

   1. Alexander Swarbrick
   2. Ghamdan Al-Eryani
   3. Sophie van der Leij
   4. Etienne Masle-Farquhar
   5. Chia-Ling Chan
   6. Kate Harvey
   7. Sunny Wu
   8. Dan Roden
   9. Taopeng Wang
   10. John Reeves
   11. Bertrand Yeung
   12. Christopher Goodnow
   13. Cindy Ma
   14. Charles Perou
   15. Nir Hacohen
   16. Aziz Al'Khafaji
   17. Mats Nilsson
   18. Joakim Lundeberg
   19. Marcel Batten
   20. Simon Junankar

3. PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation

   This article has 15 authors:

   1. Aron Lukacher
   2. Arrienne Butic
   3. Elia Afanasiev
   4. Samantha Spencer
   5. Mofida Abdelmageed
   6. Anirban Paul
   7. Kalynn Alexander
   8. Katelyn Ayers
   9. Todd Schell
   10. Matthew Lauver
   11. Ge Jin
   12. Samantha Borys
   13. Laurent Brossay
   14. Jo Anne Stratton
   15. Vonn Walter